Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study (Q45349311)
Jump to navigation
Jump to search
scientific article published in April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study |
scientific article published in April 2013 |
Statements
1 reference
Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study (English)
1 reference
1 reference
Ashley Grossman
1 reference
Dan Granberg
1 reference
Stephen Saletan
1 reference
Judith Klimovsky
1 reference
Ashok Panneerselvam
1 reference
Edward M Wolin
1 reference
1 April 2013
1 reference
Identifiers
1 reference